Somerville, E. N., James, A., Beetz, C., Schwieger, R., Barrel, G., Kandaswamy, K. K., Iurascu, M. I., Bauer, P., Ta, M., Iwaki, H., Senkevich, K., Yu, E., Alcalay, R. N., & Gan‐Or, Z. (2025). Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson’s Disease Pathogenesis. Annals of Neurology. Portico. https://doi.org/10.1002/ana.27219

Shani, S., Gana-Weisz, M., Bar-Shira, A., Thaler, A., Gurevich, T., Mirelman, A., Giladi, N., Alcalay, R. N., Orr-Urtreger, A., & Goldstein, O. (2024). P2RX7, an adaptive immune response gene, is associated with Parkinson’s disease risk and age at onset. Journal of Parkinson’s Disease. https://doi.org/10.1177/1877718x241296015

Tayran, H., Yilmaz, E., Bhattarai, P., Min, Y., Wang, X., Ma, Y., Wang, N., Jeong, I., Nelson, N., Kassara, N., Cosacak, M. I., Dogru, R. M., Reyes-Dumeyer, D., Stenersen, J. M., Reddy, J. S., Qiao, M., Flaherty, D., Gunasekaran, T. I., Yang, Z., … Kizil, C. (2024). ABCA7-dependent induction of neuropeptide Y is required for synaptic resilience in Alzheimer’s disease through BDNF/NGFR signaling. Cell Genomics, 4(9), 100642. https://doi.org/10.1016/j.xgen.2024.100642

Quintana-Gallardo, L., Bomback, A., Daina, E., Kanellis, J., Kavanagh, D., Pickering, M. C., Sunder-Plassmann, G., Walker, P., Wang, Z., Ahmad, Z., & Fakhouri, F. (2024). WCN24-683 EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN). Kidney International Reports, 9(4), S138–S139. https://doi.org/10.1016/j.ekir.2024.02.286

Griffiths, K. K., Wang, A., Jonas, E. A., & Levy, R. J. (2024). Sulfide quinone oxidoreductase contributes to voltage sensing of the mitochondrial permeability transition pore. The FASEB Journal, 38(4). Portico. https://doi.org/10.1096/fj.202301280r

Sato, T., Yamamoto, K., Matsumura, M., Moses, J., Thomas, S., Cohen, D., Mintz, G., Shlofmitz, R., Jeremias, A., Ali, Z., & Maehara, A. (2022). TCT-285 Prevalence and Anatomical Factors to Be Associated With Stent Underexpansion in Non-Severely Calcified Lesions. Journal of the American College of Cardiology, 80(12), B114–B115. https://doi.org/10.1016/j.jacc.2022.08.335

Parikh, S., Zeller, T., Shishehbor, M., Werner, M., Brodmann, M., Parise, H., Holden, A., Lichtenberg, M., Kashyap, V., Pietras, C., Tirziu, D., Ardakani, S., Beschorner, U., Krishnan, P., Niazi, K., Wali, A., & Lansky, A. (2022). TCT-209 Chocolate Touch Versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Patients With Diabetes Mellitus: Results of the Randomized Chocolate Touch Study. Journal of the American College of Cardiology, 80(12), B84. https://doi.org/10.1016/j.jacc.2022.08.246

D’Antongiovanni, V., Pellegrini, C., Benvenuti, L., Fornai, M., Di Salvo, C., Natale, G., Ryskalin, L., Bertani, L., Lucarini, E., Di Cesare Mannelli, L., Ghelardini, C., Nemeth, Z. H., Haskó, G., & Antonioli, L. (2022). RETRACTED ARTICLE: Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis. Inflammation, 45(4), 1829–1847. https://doi.org/10.1007/s10753-022-01663-8

Melville, Z., Dridi, H., Yuan, Q., Reiken, S., Wronska, A., Liu, Y., Clarke, O., & Marks, A. (2022). A drug and ATP binding site in type 1 ryanodine receptor. Acta Crystallographica Section A Foundations and Advances, 78(a1), a315–a315. https://doi.org/10.1107/s205327332209684x